Understanding how early alcohol use affects brain development and behavior in adolescents
Cortical subcortical reorganization and risk behaviors of early alcohol use initiation
This study looks at how starting to drink alcohol at a young age affects the brain and behavior in teenagers, using data from a big research project, to help find better ways to prevent problems for kids who might be at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10873801 on NIH RePORTER |
What this research studies
This research investigates the early initiation of alcohol use during adolescence and its impact on brain development and risk behaviors. By analyzing data from the Adolescent Brain Cognitive Development (ABCD) study, the researchers aim to identify neural patterns that predict early alcohol use and associated cognitive and behavioral risks. The study employs advanced analytical techniques to explore the relationship between brain structure and function and the onset of alcohol use. This understanding could lead to more effective prevention and intervention strategies for at-risk youth.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 0-20 who may be at risk for early alcohol use due to behavioral or cognitive precursors.
Not a fit: Patients who are not adolescents or who do not exhibit any behavioral or cognitive risk factors for early alcohol use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help develop targeted interventions to prevent early alcohol use and reduce the risk of substance use disorders in adolescents.
How similar studies have performed: Previous research has shown promise in identifying neural predictors of substance use behaviors, suggesting that this approach may yield valuable insights.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Potenza, Marc N — Yale University
- Study coordinator: Potenza, Marc N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.